Results of a multigene panel testing approach targeting patients with suspected genetic predisposition to pancreatic ductal adenocarcinoma

Key Points

• Pancreatic ductal adenocarcinoma is associated with specific genetic mutations, highlighting the importance of early detection.
• Multigene panel testing reveals significant biomarker correlations with genetic predisposition, leading to better prognostic insights.
• Assessment using multigene panels enables targeted genetic analysis for individuals with a family history of cancer.
• This work supports enhanced screening protocols, potentially improving outcomes for those at higher genetic risk.